Publications

Share

Evaluation of ambulatory surgery center (outcomes/safety)

  1. Musser JE, Assel MJ, Meeks JJ, et al. Ambulatory extended recovery: Safely transitioning to overnight observation for minimally invasive prostatectomy. Urology Practice. May 1 2015;2(3):121-125.
  2. Majumdar JR, Vertosick E, Long M, Cansino C, Assel M, Twersky R. Effects of midazolam on postoperative nausea and vomiting and discharge times in outpatients undergoing cancer-related surgery. AANA Journal. Jun 1 2019;87(3):179-183.
  3. Dean LW, Tin AL, Chesnut GT, et al. Contemporary management of hemorrhage after minimally invasive radical prostatectomy. Urology. Aug 1 2019;130:120-125.
  4. Majumdar JR, Vertosick EA, Cohen B, Assel M, Levine M, Barton-Burke M. Preoperative anxiety in patients undergoing outpatient cancer surgery. Asia-Pacific Journal of Oncology Nursing. Oct 1 2019;6(4):440-445.
  5. Assel MJ, Laudone VP, Twersky RS, Vickers AJ, Simon BA. Assessing rapidity of recovery after cancer surgeries in a single overnight short-stay setting. Anesthesia and Analgesia. Oct 1 2019;129(4):1007-1013.
  6. Cohen B, Levine M, Kamboj M. Clostridium difficile infection following outpatient cancer surgery. Infection Control and Hospital Epidemiology. Dec 1 2019;40(12):1440-1441.
  7. Tokita H, Twersky R, Laudone V, et al. Complex cancer surgery in the outpatient setting: The Josie Robertson Surgery Center. Review. Anesthesia and Analgesia. Sep 1 2020;131(3):699-707.
  8. Majumdar JR, Vertosick E, Assel M, et al. Reduction of postoperative nausea and vomiting and unplanned extended stays in outpatient plastic surgeries with a standardized protocol. Research Letter. Journal of Clinical Anesthesia. Nov 1 2021;74:110419.
  9. Afonso AM, McCormick PJ, Assel MJ, et al. Enhanced recovery programs in an ambulatory surgical oncology center. Anesthesia and Analgesia. Dec 1 2021;133(6):1391-1401.

Patient selection

  1. Szeto B, Vertosick EA, Ruiz K, et al. Outcomes and safety among patients with obstructive sleep apnea undergoing cancer surgery procedures in a freestanding ambulatory surgical facility. Anesthesia and Analgesia. Aug 1 2019;129(2):360-368.
  2. Simon BA, Twersky RS. In Response: Obstructive sleep apnea and perioperative outcomes: we should not confuse the probability with the established diagnosis. Anesth Analg. 2019 Sep;129(3):e107.
  3. Vertosick EA, Assel M, Tokita HK, et al. Suitability of outpatient or ambulatory extended recovery cancer surgeries for obese patients. Journal of Clinical Anesthesia. Dec 1 2019;58:111-116.
  4. Twersky RS, Szeto B, Simon B. Obstructive sleep apnea and ambulatory surgery: Who is truly at risk? Response to editorial. Correspondence. Anesthesia and Analgesia. 2020;130(1):e32.

Remote symptom monitoring (patient reported outcomes, Recovery Tracker)

  1. Stabile C, Temple LK, Ancker JS, et al. Ambulatory cancer care electronic symptom self-reporting (ACCESS) for surgical patients: A randomised controlled trial protocol. BMJ Open. Aug 1 2019;9(9):e030863.
  2. Zivanovic O, Chen LY, Vickers A, et al. Electronic patient-reported symptom monitoring in patients recovering from ambulatory minimally invasive gynecologic surgery: A prospective pilot study. Gynecologic Oncology. Oct 1 2020;159(1):187-194.
  3. Simon BA, Assel MJ, Tin AL, et al. Association between electronic patient symptom reporting with alerts and potentially avoidable urgent care visits after ambulatory cancer surgery. JAMA Surgery. Aug 1 2021;156(8):740-746.
  4. Pusic AL, Temple LK, Carter J, et al. A Randomized Controlled Trial Evaluating Electronic Outpatient Symptom Monitoring After Ambulatory Cancer Surgery. Ann Surg. 2021;274(3):441-448.
  5. Clements MB, Tin AL, Estes CL, et al. Characterization of symptoms after radical prostatectomy and their relation to postoperative complications. Journal of Urology. Feb 1 2022;207(2):367-374.
  6. Majumdar JR, Assel MJ, Lang SA, Vickers AJ, Afonso AM. Implementation of an enhanced recovery protocol in patients undergoing mastectomies for breast cancer: An interrupted time-series design. Asia-Pacific Journal of Oncology Nursing. Jul 1 2022;9(7):100047.
  7. Vickers AJ, Assel M, Hannon M, Desai P, Carlsson SV, McCready T, Cracchiolo J, Simon B. A comparison of brief versus explicit descriptors for verbal rating scales: interrupted time series design. Health Qual Life Outcomes. 2023 Sep 13;21(1):105.
  8. Majumdar JR, Fromkin JB, Yermal SJ, Fatata-Haim AM, Barton-Burke M, Jairath NN. Research Electronic Data Capture (REDCap) in an outpatient oncology surgery setting to securely email, collect, and manage survey data. J Adv Nurs. 2023 Dec 2.
  9. Myers SP, Bayard S, Tadros AB, Sevilimedu V, Matros E, Nelson JA, Le T, Garcia P, Morrow M, Lee MK. Examining Race and Patient-Reported Outcomes After Contralateral Prophylactic Mastectomy with Reconstruction. Ann Surg Oncol. 2023 Nov 16. doi: 10.1245/s10434-023-14527-8. Epub ahead of print. PMID: 37973646.
  10. Feinberg J, Zivanovic O, Hannon M, McCready T, Desai P, Kim SH, Aviki EM, Mueller JJ, Jewell EL, Roche KL, Gardner GJ, Chi DS, Sonoda Y, Brown CL, Abu-Rustum NR, Cracchiolo JR, Leitao MM Jr, Broach V. Patient-reported symptoms after minimally invasive hysterectomy and association with postoperative complications. Gynecol Oncol. 2023 Aug;175:163-168. doi: 10.1016/j.ygyno.2023.06.011. Epub 2023 Jun 28. PMID: 37390597.
  11. Srour MK, Tadros AB, Sevilimedu V, Nelson JA, Cracchiolo JR, McCready TM, Silva N, Moo TA, Morrow M. Who Are We Missing: Does Engagement in Patient-Reported Outcome Measures for Breast Cancer Vary by Age, Race, or Disease Stage? Ann Surg Oncol. 2022 Dec;29(13):7964-7973. doi: 10.1245/s10434-022-12477-1. Epub 2022 Sep 23. PMID: 36149608; PMCID: PMC10328095.
  12. Simon NB, Assel M, Serafin J, McCready TM, Nelson JA, Vickers AJ, Moo TA, Tokita HK. Patient and procedure characteristics associated with postoperative pain after prophylactic versus therapeutic ambulatory bilateral breast surgery. J Surg Oncol. 2023 Oct;128(5):719-725. doi: 10.1002/jso.27372. Epub 2023 Jun 9. PMID: 37293694; PMCID: PMC10530122.
  13. McCready TM, Stabile C, Vickers A, Ancker JS, Pusic A, Temple LKF, Simon BA, Carter J. A Remote Symptom Monitoring Tool As Part of Ambulatory Cancer Surgery Recovery: A Qualitative Analysis of Patient Experience. JCO Oncol Pract. 2023 Aug;19(8):595-601. doi: 10.1200/OP.23.00017. Epub 2023 May 26. PMID: 37235840; PMCID: PMC10424896.
  14. Chu JJ, Tadros AB, Vingan PS, Assel MJ, McCready TM, Vickers AJ, Carlsson S, Morrow M, Mehrara BJ, Stern CS, Pusic AL, Nelson JA. Remote Symptom Monitoring with Clinical Alerts Following Mastectomy: Do Early Symptoms Predict 30-Day Surgical Complications. Ann Surg Oncol. 2024 Feb 14. Online ahead of print. PMID: 38355780
  15. Cracchiolo JR, Tin AL, Assel M, McCready TM, Stabile C, Simon B, Carlsson SV, Vickers AJ, Laudone V. Electronic Patient-Reported Symptoms After Ambulatory Cancer Surgery. JAMA Surg. 2024 Mar 13:e240133. doi: 10.1001/jamasurg.2024.0133. Epub ahead of print. PMID: 38477892; PMCID: PMC10938249.
  16. Majumdar JR, Assel M, Dannaoui A, Fatata-Haim A, Fromkin J, Nelson C, Laudone V, Carlsson SV. Incorporating the Distress Thermometer into preoperative vital signs in patients undergoing ambulatory oncology surgery: a pilot feasibility study. J Psychosoc Oncol. 2024 May 17:1-6. doi: 10.1080/07347332.2024.2351038. Epub ahead of print. PMID: 38757449.

Caregiver support

  1. Griffin S, McGrath L, Chesnut GT, et al. Impact of caregiver overnight stay on postoperative outcomes. International Journal of Health Care Quality Assurance. 2019;33(1):18-26.
  2. Shaffer KM, Benvengo S, Zaleta AK, et al. Feasibility and acceptability of distress screening for family caregivers at a cancer surgery center. Oncology Nursing Forum. Mar 1 2019;46(2):159-169.
  3. Stabile C, McCready T, Ancker JS, et al. A qualitative analysis of caregiver burden during the recovery process in ambulatory cancer surgery. Support Care Cancer. 2022;30(7):5713-5721.

Opioid reduction/use

  1. Wu JX, Assel M, Vickers A, et al. Impact of intraoperative remifentanil on postoperative pain and opioid use in thyroid surgery. Journal of Surgical Oncology. Dec 15 2019;120(8):1456-1461.
  2. Fearon NJ, Benfante N, Assel M, et al. Standardizing opioid prescriptions to patients after ambulatory oncologic surgery reduces overprescription. Joint Commission Journal on Quality and Patient Safety. Jul 1 2020;46(7):410-416.
  3. Moo TA, Pawloski KR, Sevilimedu V, et al. Changing the default: A prospective study of reducing discharge opioid prescription after lumpectomy and sentinel node biopsy. Annals of Surgical Oncology. Nov 1 2020;27(12):4637-4642.
  4. Moo TA, Assel M, Yeahia R, et al. Routine opioid prescriptions are not necessary after breast excisional biopsy or lumpectomy procedures. Annals of Surgical Oncology. 2021;28(1):303-309.
  5. Pawloski KR, Sevilimedu V, Twersky R, et al. Association between local anesthetic dosing, postoperative opioid requirement, and pain scores after lumpectomy and sentinel lymph node biopsy with multimodal analgesia. Annals of Surgical Oncology. Mar 1 2022;29(3):1737-1745.
  6. Fearon NJ, Kurtzman J, Benfante N, Assel M, Vickers A, Carlsson S, Laudone VP, Levine M, Simon BA, Mehrara BJ, Nelson JA. Reducing opioid prescribing after ambulatory breast reconstruction surgery. J Surg Oncol. 2023 Dec;128(8):1235-1242.
  7. Majumdar JR, Grbic J, Carlsson S, Barreiro D, Marte M, Laudone V, Assel MJ, Masson G. Impact of Replacing Fentanyl With Hydromorphone as the First-Line Postoperative Opioid Among Patients Undergoing Outpatient Cancer Surgery. J Perianesth Nurs. 2024 Mar 15:S1089-9472(23)01051-1. doi: 10.1016/j.jopan.2023.11.007. Epub ahead of print. PMID: 38493405.
  8. Kohilakis E, et al. Gabapentin and rapidity of recovery among patients undergoing minimally invasive ambulatory uro-oncologic surgeries. Accepted for publication in Urology Practice. Mar 2024.

Intraoperative ketorolac

  1. McCormick PJ, Simon BA. ASO author reflections: We no longer give ketorolac during mastectomy. Should you? Editorial. Annals of Surgical Oncology. Sep 1 2021;28(9):5141.
  2. McCormick PJ, Assel M, Van Zee KJ, et al. Intraoperative ketorolac is associated with risk of reoperation after mastectomy: A single-center examination. Annals of Surgical Oncology. Sep 1 2021;28(9):5134-5140.
  3. McCormick PJ, Assel M, Van Zee KJ, Vickers AJ, Nelson JA, Morrow M, Tokita HK, Simon BA, Twersky RS. Reply to: “Ketorolac Following Mastectomy: Is There an Increased Risk of Reoperation?”. Ann Surg Oncol. 2021 Dec;28(Suppl 3):777-778.

Blocks

  1. Tokita HK, Assel M, Simon BA, Lin E, Sarraf L, Masson G, Pilewskie M, Vingan P, Vickers A, Nelson JA. ASO Visual Abstract: Regional Blocks Benefit Patients Undergoing Bilateral Mastectomy with Immediate Implant-Based Reconstruction, Even After Discharge. Ann Surg Oncol. 2023 Nov 10. doi: 10.1245/s10434-023-14498-w. Epub ahead of print. PMID: 37947977.
  2. Tokita HK, Assel M, Simon BA, Lin E, Sarraf L, Masson G, Pilewskie M, Vingan P, Vickers A, Nelson JA. Regional Blocks Benefit Patients Undergoing Bilateral Mastectomy with Immediate Implant-Based Reconstruction, Even After Discharge. Ann Surg Oncol. 2024 Jan;31(1):316-324. doi: 10.1245/s10434-023-14348-9. Epub 2023 Sep 25. PMID: 37747581.
  3. Ayyala HS, Assel M, Aloise J, Serafin J, Tan KS, Mehta M, Puttanniah V, McCormick P, Malhotra V, Vickers A, Matros E, Lin E. Paravertebral and erector spinae plane blocks decrease length of stay compared with local infiltration analgesia in autologous breast reconstruction. Reg Anesth Pain Med. 2024 Feb 8:rapm-2023-105031. doi: 10.1136/rapm-2023-105031. Epub ahead of print. PMID: 38336375.
  4. Vingan PS, Serafin J, Boe L, Zhang KK, Kim M, Sarraf L, Moo TA, Tadros AB, Allen R Jr, Mehrara BJ, Tokita H, Nelson JA. Reducing Disparities: Regional Anesthesia Blocks for Mastectomy with Reconstruction Within Standardized Regional Anesthesia Pathways. Ann Surg Oncol. 2024 Feb 22. doi: 10.1245/s10434-024-15094-2. Epub ahead of print. PMID: 38388930.
  5. Tokita H, Assel M, Serafin J, Lin E, Sarraf L, Masson G, Moo TA, Nelson JA, Simon BA, Vickers AJV. Optimizing accrual to a large-scale, clinically integrated randomized trial in anesthesiology: A 2-year analysis of recruitment. Clinical Trials. 2024.

Surgical techniques

  1. Pellegrino F, Tin AL, Sjoberg DD, Benfante NE, Weber RC, Porwal SP, Briganti A, Montorsi F, Eastham JA, Laudone VP, Vickers AJ. The effect of the da Vinci® Vessel Sealer on robot-assisted laparoscopic prostatectomy complications. J Robot Surg. 2023 Aug;17(4):1763-1768. doi: 10.1007/s11701-023-01595-x. Epub 2023 Apr 12. PMID: 37043122.
  2. Gaffney CD, Tin AL, Fainberg J, Fine S, Jibara G, Touijer K, Eastham J, Scardino P, Laudone V, Vickers AJ, Ehdaie B. The oncologic risk of magnetic resonance imaging-targeted and systematic cores in patients treated with radical prostatectomy. Cancer. 2023 Dec 1;129(23):3790-3796. doi: 10.1002/cncr.34981. Epub 2023 Aug 16. PMID: 37584213.
  3. Clements MB, Beech BB, Atkinson TM, Dalbagni GM, Li Y, Vickers AJ, Herr HW, Donat SM, Sjoberg DD, Tin AL, Coleman JA, Rapkin BD, Laudone VP, Bochner BH. Health-related Quality of Life After Robotic-assisted vs Open Radical Cystectomy: Analysis of a Randomized Trial. J Urol. 2023 May;209(5):901-910. doi: 10.1097/JU.0000000000003201. Epub 2023 Feb 1. PMID: 36724053; PMCID: PMC10150857.
  4. Perera M, Lebdai S, Tin AL, Sjoberg DD, Benfante N, Beech BB, Alvim RG, Touijer AS, Jenjitranant P, Ehdaie B, Laudone VP, Eastham JA, Scardino PT, Touijer KA. Oncologic outcomes of patients with lymph node invasion at prostatectomy and post-prostatectomy biochemical persistence. Urol Oncol. 2023 Feb;41(2):105.e19-105.e23. doi: 10.1016/j.urolonc.2022.10.021. Epub 2022 Nov 24. PMID: 36435708; PMCID: PMC10391319.
  5. Leitao MM Jr, Kreaden US, Laudone V, Park BJ, Pappou EP, Davis JW, Rice DC, Chang GJ, Rossi EC, Hebert AE, Slee A, Gonen M. The RECOURSE Study: Long-term Oncologic Outcomes Associated With Robotically Assisted Minimally Invasive Procedures for Endometrial, Cervical, Colorectal, Lung, or Prostate Cancer: A Systematic Review and Meta-analysis. Ann Surg. 2023 Mar 1;277(3):387-396. doi: 10.1097/SLA.0000000000005698. Epub 2022 Sep 8. PMID: 36073772; PMCID: PMC9905254.